Literature DB >> 9063849

Healing of a tibial double osteotomy is modified by clodronate administration.

M T Nyman1, T Gao, T C Lindholm, T S Lindholm.   

Abstract

We studied the healing of tibial double osteotomies in rats during clodronate administration 10 mg/kg daily subcutaneously for 6 weeks. Clodronate treatment did not inhibit the endochondral bone formation in callus or in the epiphyseal plate. The differentiation of osteoblasts into mature osteocytes was disturbed, and the bone structure around the osteocytes was not normal. In the clodronate-treated group, the amount of newly formed bone matrix seemed increased, but mineralization of the bone matrix was delayed. The bundle bone trabeculae in callus were not so spatially well organized as in the controls. No delay in the union of the bone segment by new bone was seen during clodronate administration.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9063849     DOI: 10.1007/bf00573453

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  14 in total

1.  Normal osteoid tissue.

Authors:  V Raina
Journal:  J Clin Pathol       Date:  1972-03       Impact factor: 3.411

Review 2.  Cellular biology and biochemical mechanism of bone resorption. A review of recent developments on the formation, activation, and mode of action of osteoclasts.

Authors:  G Vaes
Journal:  Clin Orthop Relat Res       Date:  1988-06       Impact factor: 4.176

3.  Treatment and prevention of osteoporosis in juvenile chronic arthritis with disodium clodronate.

Authors:  L Lepore; M Pennesi; E Barbi; R Pozzi
Journal:  Clin Exp Rheumatol       Date:  1991 Jan-Feb       Impact factor: 4.473

Review 4.  Rationale for the use of clodronate in osteoporosis.

Authors:  J A Kanis; E V McCloskey; P Sirtori; S Khan; D Fern; K Eyres; J Aaron; M N Beneton
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

5.  Clodronate increases the calcium content in fracture callus. An experimental study in rats.

Authors:  M T Nyman; P Paavolainen; T S Lindholm
Journal:  Arch Orthop Trauma Surg       Date:  1993       Impact factor: 3.067

6.  Cortical osteoclasts are less sensitive to etidronate than trabecular osteoclasts.

Authors:  D Chappard; M Petitjean; C Alexandre; L Vico; P Minaire; G Riffat
Journal:  J Bone Miner Res       Date:  1991-07       Impact factor: 6.741

7.  Clodronate reduces plate osteopenia in the rabbit.

Authors:  M T Nyman; P Paavolainen; T Holmström; R Penttinen; M Verkasalo
Journal:  Acta Orthop Scand       Date:  1993-02

8.  Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (Cl 2 MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats.

Authors:  R Schenk; W A Merz; R Mühlbauer; R G Russell; H Fleisch
Journal:  Calcif Tissue Res       Date:  1973-03-12

9.  Dichloromethylenebisphosphonate (Cl2MBP) inhibits bone resorption through injury to osteoclasts that resorb Cl2MBP-coated bone.

Authors:  A M Flanagan; T J Chambers
Journal:  Bone Miner       Date:  1989-04

10.  Effects of bisphosphonates on the incorporation of calcium-45 and 3H-proline in orthotopic and in demineralized matrix-induced bone in rats.

Authors:  H C Bauer; H Törnkvist; O S Nilsson
Journal:  Bone       Date:  1986       Impact factor: 4.398

View more
  4 in total

Review 1.  [The influence of bisphosphonates on fracture healing].

Authors:  C Seebach; A Kurth; I Marzi
Journal:  Orthopade       Date:  2007-02       Impact factor: 1.087

2.  The effects of RANKL inhibition on fracture healing and bone strength in a mouse model of osteogenesis imperfecta.

Authors:  Demetris Delos; Xu Yang; Benjamin F Ricciardi; Elizabeth R Myers; Mathias P G Bostrom; Nancy Pleshko Camacho
Journal:  J Orthop Res       Date:  2008-02       Impact factor: 3.494

3.  Managing osteoporosis in patients with fragility fractures: did the British Orthopaedic Association guidelines have any impact?

Authors:  M F Nixon; T Ibrahim; Y Johari; S Eltayef; D Hariharan; G J Taylor
Journal:  Ann R Coll Surg Engl       Date:  2007-07       Impact factor: 1.891

4.  Tiludronate and clodronate do not affect bone structure or remodeling kinetics over a 60 day randomized trial.

Authors:  Heather A Richbourg; Colin F Mitchell; Ashley N Gillett; Margaret A McNulty
Journal:  BMC Vet Res       Date:  2018-03-20       Impact factor: 2.741

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.